Mega EGCG

Mega EGCG

$27.60
RV41

Mega EGCG is a practitioner-only listed medicine containing concentrated Camellia sinensis leaf extract, standardised to provide epigallocatechin-3-gallate (EGCG) 225 mg and caffeine 20 mg per capsule. It is intended for qualified healthcare practitioners seeking antioxidant support, free radical reduction and thermogenesis support.

60 x 500 mg capsules | AUST L 135054

Each 500 mg capsule contains:

Camellia sinensis leaf dry extract 500 mg
Equivalent to dry Camellia sinensis leaf 5 g
Containing epigallocatechin-3-gallate (EGCG) 225 mg
Containing caffeine 20 mg

Extract ratio: 10:1
Extraction solvent: purified water 100%

Mega EGCG is formulated to:

  • provide antioxidant activity
  • help reduce free radicals formed in the body
  • maintain / support heat and energy production
  • maintain / support thermogenesis

Directions

Take 1 capsule up to 3 times daily with food, or as directed by a qualified healthcare practitioner.

Maximum daily dose: 3 capsules daily.

Maximum single dose: 1 capsule.

Dosage and duration should be determined by the treating healthcare practitioner based on individual assessment and must not exceed the ARTG-listed maximum daily or single dose.

Warnings

Adults only.

Contains 20 mg total caffeine per capsule. A cup of instant coffee contains approximately 80 mg of caffeine.

Caffeine intake more than 200 mg per day is not recommended during pregnancy or breastfeeding.

In rare cases, Camellia sinensis may harm the liver. Stop use and see a doctor if you have yellowing skin or eyes, or unusual fatigue, nausea, appetite loss, abdominal pain, dark urine or itching.

To be taken with food.

This section is provided for qualified healthcare practitioners as professional education. It summarises selected ingredient-level and pathway-level research relating to Camellia sinensis, EGCG, antioxidant activity, free radical reduction and thermogenesis. It does not represent additional ARTG indications for Mega EGCG.

Mega EGCG is relevant to practitioners interested in green tea catechins, EGCG research, antioxidant pathways, oxidative stress, cellular signalling, thermogenesis and energy production research.

EGCG is a major catechin found in Camellia sinensis green tea extract. It has been widely discussed in professional literature in relation to antioxidant activity, oxidative stress pathways, cellular signalling, protein aggregation research, inflammatory pathway research and metabolic pathway research.

Green tea polyphenols, including EGCG, have also been studied in neurodegenerative disease research settings, including Alzheimer’s and Parkinson’s disease mechanisms. Recent review literature discusses green tea polyphenols in relation to oxidative stress, impaired proteostasis and metal ion dyshomeostasis in neurodegenerative disease research. This information is provided as scientific background only and should not be interpreted as a claim that Mega EGCG treats, prevents or improves Alzheimer’s disease, Parkinson’s disease, dementia or any neurodegenerative condition.

Recent EGCG review literature has also examined molecular mechanisms and clinical research relating to neuroprotection. This supports practitioner education around EGCG’s broader research profile, but does not create additional therapeutic indications for Mega EGCG.

Practitioners should also be aware of the safety profile of concentrated green tea extracts. The TGA has advised that rare cases of liver harm have been associated with Camellia sinensis extracts, and this should be considered when assessing suitability, dose, duration of use and patient monitoring.

The combination of green tea extract, EGCG and naturally occurring caffeine supports practitioner education around antioxidant activity, free radical reduction, thermogenesis and heat / energy production.

This information is provided for practitioner education only and does not represent additional ARTG indications for Mega EGCG.

References available to registered practitioners on request.